SentryX is excited to announce its participation in the European Innovation Council’s (EIC) upcoming USA Soft-landing Program. Together with some of the most promising EIC life sciences companies, SentryX will enjoy six weeks of coaching and support followed by one week of being immersed in the health and life sciences ecosystem of San Francisco and Silicon Valley, starting on May 19^th: https://eic.eismea.eu/community/stories/eu-companies-have-immersive-experience-us-market-thanks-eic-usa-soft-landing-programme.

The USA Soft Landing Program could be an important step for SentryX’s implantable anesthetics. The company will be connecting with leading US healthcare innovators, research institutes, and investors who can help us on our mission to keep an ageing population mobile through musculoskeletal surgery without the detriments of pain and opioids.